Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.37 (
DNA methyltransferase
)
4,983
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Idiopathic (immune) thrombocytopenic purpura (
ITP
) is a heterogeneous clinical disorder characterized by immune-mediated platelet destruction. Epigenetic changes in gene expression, including DNA methylation and histone modifications, might contribute to autoimmunity. Polymorphisms of the
DNA methyltransferase
3B (DNMT3B) gene may influence DNMT3B activity on DNA methylation and increase the susceptibility to several diseases. The current study investigated the association between a single nucleotide polymorphism (SNP) in the promoter of DNMT3B gene and the risk for
ITP
in pediatric Egyptians. DNMT3B SNP was genotyped by PCR-restriction fragment length polymorphism in 71 pediatric
ITP
patients and 82 healthy controls matched for age and sex. The C/C wild genotype was not detected in
ITP
patients or in the controls. The frequencies of the T/T and C/T genotypes were 93.9 and 6.1% in the controls and 91.5 and 6.1% in
ITP
patients, respectively. There was no significant difference in either genotypes or allelic distribution between
ITP
patients and the controls. In conclusion, this polymorphism was almost equally distributed between
ITP
patients and the controls. These results demonstrated that this SNP may not be used as a stratification marker to predict the susceptibility to childhood
ITP
in Egypt.
...
PMID:DNMT3B promoter polymorphism and risk of immune thrombocytopenic purpura in pediatric Egyptians. 2288 66